A Pilot, prospective, single-center Human Clinical Trial Assessing Safety and Initial Efficacy of OTX-TIC (outside the United States trial)
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Travoprost (Primary) ; Travoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- 07 Nov 2017 In the third quarter of 2017, Status changed to recruiting, according to an Ocular Therapeutix media release.
- 14 Aug 2017 New trial record
- 08 Aug 2017 According to an Ocular Therapeutix media release, the company expects to initiate this pilot human clinical trial in 2017.